loadpatents
name:-0.014410018920898
name:-0.010555028915405
name:-0.0052990913391113
Rabow; Alfred Arthur Patent Filings

Rabow; Alfred Arthur

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rabow; Alfred Arthur.The latest application filed is for "1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseases".

Company Profile
5.9.13
  • Rabow; Alfred Arthur - Cambridge GB
  • Rabow; Alfred Arthur - Cheshire GB
  • Rabow; Alfred Arthur - Macclesfield GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
[1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseases
Grant 11,407,755 - Bradbury , et al. August 9, 2
2022-08-09
1,2,4]triazolo[4,3-b]pyridazines For Use In The Treatment Of Proliferative Diseases
App 20210107905 - BRADBURY; Robert Hugh ;   et al.
2021-04-15
[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseases
Grant 10,766,905 - Bradbury , et al. Sep
2020-09-08
[1,2,4]triazolo[4,3-b]pyridazines For Use In The Treatment Of Proliferative Diseases
App 20200055861 - Bradbury; Robert Hugh ;   et al.
2020-02-20
[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseases
Grant 10,407,432 - Bradbury , et al. Sept
2019-09-10
Chemical Compounds
App 20190038607 - Bradbury; Robert Hugh ;   et al.
2019-02-07
Chemical compounds
Grant 10,130,617 - Bradbury , et al. November 20, 2
2018-11-20
[1,2,4]triazolo[4,3-b]pyridazines For Use In The Treatment Of Proliferative Diseases
App 20180230158 - BRADBURY; Robert Hugh ;   et al.
2018-08-16
[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseases
Grant 9,944,650 - Bradbury , et al. April 17, 2
2018-04-17
Chemical Compounds
App 20170326115 - Bradbury; Robert Hugh ;   et al.
2017-11-16
[1,2,4]triazolo[4,3-b]pyridazines For Use In The Treatment Of Proliferative Diseases
App 20170210747 - Bradbury; Robert Hugh ;   et al.
2017-07-27
Chemical compounds
Grant 9,616,050 - Bradbury , et al. April 11, 2
2017-04-11
Chemical Compounds
App 20160136140 - Bradbury; Robert Hugh ;   et al.
2016-05-19
Chemical compounds
Grant 9,155,727 - Bradbury , et al. October 13, 2
2015-10-13
Chemical Compounds
App 20140357661 - BRADBURY; Robert Hugh ;   et al.
2014-12-04
Chemical Compounds - 643
App 20130203714 - Bradbury; Robert Hugh ;   et al.
2013-08-08
Chemical compounds--643
Grant 8,258,140 - Bradbury , et al. September 4, 2
2012-09-04
Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155
Grant 8,003,649 - Bradbury , et al. August 23, 2
2011-08-23
Chemical Compounds 751
App 20100292222 - Bradbury; Robert Hugh ;   et al.
2010-11-18
Chemical Compounds - 643
App 20100267699 - Bradbury; Robert Hugh ;   et al.
2010-10-21
Bicyclic Derivatives For Use In The Treatment Of Androgen Receptor Associated Conditions-155
App 20100016279 - Bradbury; Robert Hugh ;   et al.
2010-01-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed